PerkinElmer plans to use its roughly $400 million in proceeds from the sale of two businesses to focus its efforts going forward primarily on the health sciences market.

The divestitures of its aerospace business and semiconductor and fluid-testing businesses also will enable the company to repay its debt, which currently stands at $270 million and has been the primary reason PerkinElmer has been relatively quiet on the acquisition front for the past few years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.